semaglutide court Novo Nordisk faces off in with South African weight-loss drug compounder A South African court has

GLP-1 medications such as Wegovy, Ozempic, and Zepbound have become increasingly popular for treating obesity and Type 2 diabetes, but insurance coverage for these medications remains inconsistent and financially challenging for consumers who have resorted to getting their GLP1s through other avenues

A., & Tronieri, J

10.1172/JCI38151 27

However, the specific neurons within the VMN involved in these processes have not been fully elucidated

A new LFT score has been shown to be accurate in categorizing the metabolic associated steatotic liver disease (MASLD) patients into cholestatic, mixed or hepatocellular subtype to help with prognostic assessments (109)

The medication follows the same titration schedule regardless of sex: starting at 0.25mg weekly and increasing to the maintenance dose of 2.4mg over approximately four months